From: The role of prognostic nutritional index in the management of pulmonary sarcomatoid carcinoma
OS | Univariate analysis | Multivariate analysis | RFS | Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
P value | X2 | HR | 95% CI | P value | P value | X2 | HR | 95% CI | P value | ||
Age <= 60 vs. > 60 | 0.585 | 0.298 | 0.564 | 0.333 | |||||||
Sex Male vs. Female | 0.897 | 0.017 | 0.949 | 0.004 | |||||||
Smoking history Yes vs. No | 0.963 | 0.002 | 0.942 | 0.005 | |||||||
Alcohol abuse Yes vs. No | 0.551 | 0.356 | 0.623 | 0.242 | |||||||
Tumor size > 5 vs. <= 5 cm | 0.008 | 7.045 | 1.311 | 0.442-3.886 | 0.625 | 0.012 | 6.373 | 1.770 | 0.585–5.349 | 0.312 | |
Tumor stage T3–4 vs. T1–2 | 0.062 | 3.496 | 0.091 | 2.860 | |||||||
Tumor location Peripheral vs. Central | 0.194 | 1.687 | 0.157 | 2.001 | |||||||
Nodal metastasis Positive vs. Negative | < 0.001 | 14.076 | 1.164 | 0.451–3.004 | 0.753 | < 0.001 | 27.165 | 3.328 | 1.105–10.022 | 0.033 | |
Pathological stage IIb–IIIc vs. Ia–IIa | < 0.001 | 15.921 | 1.658 | 0.981–2.805 | 0.059 | <0.001 | 17.590 | 1.230 | 0.723–2.095 | 0.445 | |
Treatment modality | 0.001 | 11.621 | 0.035 | 0.005 | 7.783 | 0.487 | |||||
S + CT/S | 0.288 | 0.095–0.874 | 0.028 | 0.649 | 0.248–1.700 | 0.379 | |||||
S + CT + Targeted therapy/S | 0.148 | 0.030–0.726 | 0.019 | 0.407 | 0.86–1.923 | 0.257 |